Mobiliteitsprestatie in Dagelijkse Activiteiten bij Kinderen die een Bril Dragen

Inclusion Criteria:

A participant is eligible for inclusion in the study if they meet the following criteria:

• Are between the ages of 6 and 12 years of age (inclusive) at the time of informed consent/assent.
• Can achieve a corrected visual acuity of 20/20 best-corrected (or equivalent logMAR).
• Have undergone a self-reported oculo-visual examination within the past two years.
• Have no active ocular disease.
• Are willing and able to adhere to instructions, study procedures, and maintain the appointment schedule.
• Have not previously worn or participated in myopia control contact lenses for more than one month and are not currently undergoing any form of myopia control treatment.
• The subject's parent(s) or legal guardian(s) must read, understand, and sign the Statement of Informed Consent and receive a fully executed copy of the form.

Exclusion Criteria:

A participant will be excluded from the study if they meet any of the following conditions:

• Have any systemic disease that affects ocular health.
• Are currently using or have used, within the past 7 days, any systemic or topical medications that may impact ocular health.
• Are currently using or have used any topical ophthalmic agents with anti-muscarinic properties within 7 days prior to enrollment or at any point during the study. This includes, but is not limited to, atropine, scopolamine, pirenzepine, tropicamide, cyclopentolate, and homatropine.
• Have used any oral agents with anti-muscarinic properties for a chronic period (2 months or more) or short-term (within 7 days prior to enrollment). This includes, but is not limited to, gastrointestinal anti-spasmodic medications containing atropine, hyoscyamine, and dicyclomine.
• Have known developmental delays.
• Have participated in another clinical study in the last 7 days